We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bacterial Toxin Shows Promise as Potential Anticancer Drug

By LabMedica International staff writers
Posted on 21 Jun 2015
Print article
Image: False color scanning electron micrograph of Vibrio vulnificus bacteria (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Image: False color scanning electron micrograph of Vibrio vulnificus bacteria (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
A toxin that increases the virulence of the bacteria that produce it shows promise as a potential anticancer agent.

The bacterium Vibrio vulnificus produces and secretes a toxin of the MARTX (multifunctional-autoprocessing repeats-in-toxin) family. MARTX toxins serve as delivery platforms for cytotoxic effector domains. One of these effector domains, called the domain of unknown function in position 5 (DUF5), has been shown to increase the potency of the V. vulnificus MARTX toxin in mouse virulence studies, indicating DUF5 directly contributes to pathogenesis. DUF5 is localized in the plasma membrane dependent upon its C1 domain, and the cells become rounded dependent upon its C2 domain.

In the current study, investigators at Northwestern University (Chicago, IL, USA) used a combination of genetic, cell biological, and biochemical strategies to probe the mechanism of action of the MARTX C2 domain, to understand the connection of DUF5 to both cytotoxicity and increased virulence of the pathogen.

They reported in the June 8, 2015, online edition of the journal Nature Communications that DUF5 was a site-specific endopeptidase that cleaved both Ras and the closely related small GTPase Rap1. Both proteins are critical for activation of the innate immune response during infection, which explains the crucial role of this effector domain in the increased virulence of V. vulnificus strains that have DUF5.

In addition, the investigators showed that the V. vulnificus MARTX protein could inhibit cancer cell growth by deactivating Ras. This linkage seems justified, as Ras signaling stimulates cell growth and division, and overactive Ras signaling can ultimately lead to cancer. Ras is the most common oncogene in human cancer—mutations that permanently activate Ras are found in 20%–25% of all human tumors and up to 90% in certain types of cancer such as pancreatic cancer.

"What is unique about this study is the ability of the toxin to cleave Ras, rather than modify it, which is a novel mechanism for inactivating Ras," said senior author Dr. Karla Satchell, professor of microbiology and immunology at Northwestern University. "Ras is important for cell proliferation in cancer, so the toxin could potentially be developed as a treatment for different types of tumors. It has been known that Ras has a role in cancer development, and targeting Ras has been one of the hardest challenges of cancer research and drug discovery."

Related Links:

Northwestern University


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
Silver Member
Static Concentrator
BJP 10
New
ELISA System
ABSOL HS DUO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.